for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Novavax Sees Phase 2 Trial Of Nanoflu Vaccine To Begin In Q3 2018

Feb 28 (Reuters) - Novavax Inc:

* SAYS PHASE 2 TRIAL OF NANOFLU VACCINE EXPECTED TO BEGIN IN Q3 OF 2018

* ANNOUNCES POSITIVE TOP-LINE RESULTS FROM ITS PHASE 1/2 CLINICAL TRIAL IN OLDER ADULTS OF ITS NANOFLU RECOMBINANT INFLUENZA VACCINE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up